Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Blackhawk Growth Corp C.BLR

Alternate Symbol(s):  C.BLR.WT | BLRZF

Blackhawk Growth Corp. is a Canada-based investment holding company. The Company invests in equity and debt instruments of companies to generate positive returns for shareholders. It focuses on investing in multiple companies across a variety of sectors across North America. The Company has focused its investments on the health, cannabis and cannabidiol (CBD) industries, in both Canada and the United States.


CSE:BLR - Post by User

Bullboard Posts
Post by bveilleuon Oct 19, 2020 9:19am
219 Views
Post# 31738114

BLR Receives Confirmation from HC and provides update

BLR Receives Confirmation from HC and provides update

Vancouver, British Columbia - TheNewswire - October 19, 2020 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (the “Corporation” or “Blackhawk”), is pleased to provide the following corporate update.

The Health Canada Interim Order (“IO”) application was completed and submitted for the ExProbe SARS-CoV-2 Testing Kit. The Company received confirmation of receipt from Health Canada on October 14, 2020. Even though Blackhawk cannot guarantee timelines, the anticipated time to process the application is between 40 and 60 days.

The IO process for the SARS-CoV-2 IgG/IgM Rapid Test Kit is scheduled to be submitted as soon as it is completed. The application process, though similar, has many more parameters and thus requires more time to prepare. Health Canada timelines will vary on a case by case basis for an IO application review. As we understand, currently this duration is closer to 4 weeks from the time of submission but could take longer depending on the extent of information requests received from Health Canada.

Blackhawk makes no representations or provide any guarantees on Health Canada review timelines, or that any particular application will be successful.

We would also like to confirm that Blackhawk has obtained its Medical Device Establishment License (MDEL) and will be acting as the agent for the manufacturer in Canada. The ExProbe SARS-CoV-2 Testing Kit was submitted with Blackhawk as the agent.


Click Image To View Full Size

 

NuWave Foods

NuWave is expecting to receive the finalized contract for its larger-scale equipment this week as negotiations have completed. NuWave has added multiple baked goods to its exclusivity to be produced in its Edmonton facility. NuWave has also added exclusivity for the drying of psilocybin mushrooms internationally where regulations or licencing allow. The Company will provide further updates when they become available.

Trip Pharma

Trip Pharma has secured the location for its first Canadian clinic. The clinic will be Situated on a prominent corner of the warehouse district in Edmonton's historic MacCosham building. Modifications and outfitting are currently underway. Trip Pharma plans to keep the character of the original architectural features including the heavy wooden beams and columns, brick walls, hardwood floors and heavy timber ceilings. Utilizing just under 5,000 Sq feet on the main and second floors, the clinic is spacious enough for exam rooms built for the post-pandemic era. Initial staff has been secured and Dr. Krista Leicht intends to move her current practice to this facility as soon as upgrades have been completed. At capacity, the clinic will be able to support 11 medical professionals. The intended occupants of this clinic will be Psychiatrists, Psychologists, and General Practitioners. Blackhawk’s “Talk to Doc” platform will be the official telemedicine platform for the Trip Pharma clinic.

Picture of the clinic below – more pictures will be available upon completion of the upgrades.


Click Image To View Full Size

 

 

For further information please contact:

Frederick Pels, Chief Executive Officer

(403)-991-7737

fred@blackhawkgrowth.com

Bullboard Posts